XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Current assets    
Cash and cash equivalents $ 1,540us-gaap_CashAndCashEquivalentsAtCarryingValue $ 2,164us-gaap_CashAndCashEquivalentsAtCarryingValue
Other current assets 631us-gaap_OtherAssetsCurrent 555us-gaap_OtherAssetsCurrent
Total current assets 2,171us-gaap_AssetsCurrent 2,719us-gaap_AssetsCurrent
Patent license rights, net 627us-gaap_FiniteLivedIntangibleAssetsNet 666us-gaap_FiniteLivedIntangibleAssetsNet
Furniture and equipment, net 0us-gaap_PropertyPlantAndEquipmentNet 0us-gaap_PropertyPlantAndEquipmentNet
Total assets 2,798us-gaap_Assets 3,385us-gaap_Assets
Current liabilities    
Accounts payable 185us-gaap_AccountsPayableCurrent 124us-gaap_AccountsPayableCurrent
Other accrued liabilities 180us-gaap_AccruedLiabilitiesCurrent 158us-gaap_AccruedLiabilitiesCurrent
Total current liabilities 365us-gaap_LiabilitiesCurrent 282us-gaap_LiabilitiesCurrent
Capstone Therapeutics Corp. Stockholders' Equity    
Common Stock $.0005 par value; 100,000,000 shares authorized; 40,885,411 shares in 2015 and 2014 issued and outstanding 20us-gaap_CommonStockValue 20us-gaap_CommonStockValue
Additional paid-in capital 189,314us-gaap_AdditionalPaidInCapitalCommonStock 189,268us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated deficit (186,901)us-gaap_RetainedEarningsAccumulatedDeficit (186,185)us-gaap_RetainedEarningsAccumulatedDeficit
Total Capstone Therapeutics Corp. stockholders' equity 2,433us-gaap_StockholdersEquity 3,103us-gaap_StockholdersEquity
Noncontrolling interest 0us-gaap_MinorityInterest 0us-gaap_MinorityInterest
Total equity 2,433us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 3,103us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Total liabilities and equity $ 2,798us-gaap_LiabilitiesAndStockholdersEquity $ 3,385us-gaap_LiabilitiesAndStockholdersEquity